BAX
Baxter International Inc
NYSE: BAX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$17.53
-2.56% today
Updated 2026-05-11
Market cap
$9.05B
P/E ratio
—
P/S ratio
0.80x
EPS (TTM)
$-1.91
Dividend yield
2.00%
52W range
$16 – $32
Volume
8.6M
WallStSmart proprietary scores
51
out of 100
Grade: C
Hold
Investment rating
6.0
Growth
B6.0
Quality
B3.5
Profitability
D5.7
Valuation
C+4/9
Piotroski F-Score
Moderate
2.0
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →198 stocks currently score above 75
Price targets
Analyst target
$22.12
+26.18%
12-Month target
—
—
Intrinsic (DCF)
$60.34
Margin of safety
+63.09%
1 Strong Buy2 Buy12 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $76.00M — positive
+ 63.09% below intrinsic value
Risks
- Thin margins at -9.70%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $10.06B | $10.36B | $10.64B | $11.24B | $11.32B |
| Net income | $-2.43B | $2.66B | $-649.00M | $-957.00M | $-15.00M |
| EPS | — | — | — | — | $-1.91 |
| Free cash flow | $532.00M | $1.29B | $559.00M | $323.00M | $76.00M |
| Profit margin | -24.19% | 25.64% | -6.10% | -8.51% | -9.70% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-05 | WILKES, DAVID S. | Buy | 12,836 | — |
| 2026-05-05 | WENDELL, AMY MCBRIDE | Buy | 12,836 | — |
| 2026-05-05 | SHAFER, DAVID BRENT | Buy | 12,836 | — |
Peer comparison
Smart narrative
Baxter International Inc trades at $17.53. Our Smart Value Score of 51/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 1.98, it sits in the grey zone. TTM revenue stands at $11.32B. with profit margins at -9.70%. Our DCF model estimates intrinsic value at $60.34.
Frequently asked questions
What is Baxter International Inc's stock price?
Baxter International Inc (BAX) trades at $17.53.
Is Baxter International Inc overvalued?
Smart Value Score 51/100 (Grade C, Hold). DCF value $60.34.
What is the price target of Baxter International Inc (BAX)?
The analyst target price is $22.12, representing +26.2% upside from the current price of $17.53.
What is the intrinsic value of Baxter International Inc (BAX)?
Based on our DCF model, intrinsic value is $60.34, a +63.1% margin of safety versus $17.53.
What is Baxter International Inc's revenue?
TTM revenue is $11.32B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
1.98 — grey zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.80x
ROE-15.00%
Beta0.62
50D MA$17.50
200D MA$20.41
Shares out0.52B
Float0.51B
Short ratio—
Avg volume8.6M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—